These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

607 related items for PubMed ID: 16635751

  • 1. Genetic association of interleukin-1beta and receptor antagonist (IL-1Ra) gene polymorphism with allograft function in renal transplant patients.
    Manchanda PK, Bid HK, Kumar A, Mittal RD.
    Transpl Immunol; 2006 Apr; 15(4):289-96. PubMed ID: 16635751
    [Abstract] [Full Text] [Related]

  • 2. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.
    Langdahl BL, Løkke E, Carstens M, Stenkjaer LL, Eriksen EF.
    J Bone Miner Res; 2000 Mar; 15(3):402-14. PubMed ID: 10750554
    [Abstract] [Full Text] [Related]

  • 3. Influence of genetic polymorphisms in GSTM1, GSTM3, GSTT1 and GSTP1 on allograft outcome in renal transplant recipients.
    Singh R, Manchanda PK, Kesarwani P, Srivastava A, Mittal RD.
    Clin Transplant; 2009 Mar; 23(4):490-8. PubMed ID: 19486347
    [Abstract] [Full Text] [Related]

  • 4. Postoperative pain, morphine consumption, and genetic polymorphism of IL-1beta and IL-1 receptor antagonist.
    Bessler H, Shavit Y, Mayburd E, Smirnov G, Beilin B.
    Neurosci Lett; 2006 Aug 14; 404(1-2):154-8. PubMed ID: 16777324
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Decreasing plasma soluble IL-1 receptor antagonist and increasing monocyte activation early post-transplant may be involved in pathogenesis of delayed graft function in renal transplant recipients.
    Sadeghi M, Daniel V, Naujokat C, Schmidt J, Mehrabi A, Zeier M, Opelz G.
    Clin Transplant; 2010 Aug 14; 24(3):415-23. PubMed ID: 19925477
    [Abstract] [Full Text] [Related]

  • 7. Impact of donor-dependent genetic factors on long-term renal graft function.
    Krajewska M, Kościelska-Kasprzak K, Weyde W, Drulis-Fajdasz D, Madziarska K, Mazanowska O, Kusztal M, Klinger M.
    Transplant Proc; 2009 Oct 14; 41(8):2978-80. PubMed ID: 19857655
    [Abstract] [Full Text] [Related]

  • 8. Genetic association of interleukin-4, interleukin-10, and transforming growth factor-beta gene polymorphism with allograft function in renal transplant patients.
    Amirzargar M, Yavangi M, Basiri A, Moghadam SH, Khosravi F, Solgi G, Gholiaf M, Khoshkho F, Dadaras F, Mahmmodi M, Ansaripour B, Amirzargar A, Nikbin B.
    Transplant Proc; 2007 May 14; 39(4):954-7. PubMed ID: 17524861
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The combination of the interleukin-1alpha (IL-1alpha-889) genotype and the interleukin-10 (IL-10 ATA) haplotype is associated with increased interleukin-10 (IL-10) plasma levels in healthy individuals.
    Kilpinen S, Huhtala H, Hurme M.
    Eur Cytokine Netw; 2002 May 14; 13(1):66-71. PubMed ID: 11956022
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Molecular genetic analysis of interleukin-1 promoter and receptor antagonist tandem repeat polymorphisms among HLA-identical renal transplant recipient and donor pairs.
    Jin Y, Ruiz P.
    Transplant Proc; 2008 Jun 14; 40(5):1329-32. PubMed ID: 18589098
    [Abstract] [Full Text] [Related]

  • 15. Association of polymorphisms in CTLA-4, IL-1ra and IL-1beta genes with multiple sclerosis in Serbian population.
    Dincić E, Zivković M, Stanković A, Obradović D, Alavantić D, Kostić V, Raicević R.
    J Neuroimmunol; 2006 Aug 14; 177(1-2):146-50. PubMed ID: 16769128
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
    Heresbach D, Alizadeh M, Dabadie A, Le Berre N, Colombel JF, Yaouanq J, Bretagne JF, Semana G.
    Am J Gastroenterol; 1997 Jul 14; 92(7):1164-9. PubMed ID: 9219791
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Study on the polymorphism of interleukin-1 gene and the susceptibility to essential hypertension].
    Li Y, Xu P, Zhang PA, Li XY, Huang CX.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Oct 14; 21(5):491-3. PubMed ID: 15476179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.